General information | Experimental group | Reference group | t/x2 | P | |
gender | man | 16 | 18 | 0.251 | >0.05 |
woman | 16 | 14 | |||
Average age | 46.30 ± 5.36 | 46.28 ± 5.31 | 0.015 | >0.05 | |
Mean course of illness | 3.55 ± 1.36 | 3.51 ± 1.32 | 0.067 | >0.05 | |
by stages | Phase I | 9 | 8 | 0.275 | >0.05 |
Stage II | 15 | 17 | |||
Stage III | 6 | 5 |